Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis
NCT01961310 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2025-11-21
Summary
The main objective of this study is to compare the intestinal microbiota in newly diagnosed rheumatoid arthritis (RA) with that from individuals without RA.
The first analysis will compare the proportion of filamentous bacteria in the intestinal microbiota between the two groups.
Conditions
- Arthritis, Rheumatoid
Interventions
- BIOLOGICAL
-
Plasma analysis for bacterial translocation
1 ml of plasma will be obtained (blood sample). DNA will be extracted and amplified, and real-time quantitative PCR (polymerase chain reaction) performed.
- BIOLOGICAL
-
Stool analysis
DNA from stool samples will be extracted, amplified, and used to identify the bacteria species present.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Principal Investigators
-
Catherine Dunyach-Rempy, PharmD, PhD · Centre Hospitalier Universitaire de Nîmes
-
Jean Philippe Lavigne, MD, PhD · Centre Hospitalier Universitaire de Nîmes
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-08
- Primary Completion
- 2018-03-29
- Completion
- 2018-03-29
Countries
- France
Study Locations
More Related Trials
-
The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis
NCT00001375 ·Status: COMPLETED
-
Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France
NCT02927509 ·Status: COMPLETED
-
Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients
NCT04679272 ·Status: COMPLETED
-
Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
NCT01111357 ·Status: COMPLETED
-
Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab
NCT01981473 ·Status: COMPLETED
-
Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases
NCT04655612 ·Status: COMPLETED
-
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291 ·Status: COMPLETED
-
Study During Pregnancy of Expression of miRNAs in RA or SLE
NCT02350491 ·Status: COMPLETED
-
Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).
NCT01577563 ·Status: COMPLETED
-
Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment
NCT00929357 ·Status: COMPLETED
-
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
NCT01557322 ·Status: COMPLETED
-
Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy
NCT02531061 ·Status: COMPLETED ·Phase: NA
-
Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases
NCT04353609 ·Status: COMPLETED
-
Rheumatology Biorepository
NCT04899895 ·Status: ENROLLING_BY_INVITATION
-
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
NCT02804204 ·Status: UNKNOWN
-
Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity
NCT05570513 ·Status: NOT_YET_RECRUITING
-
An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis
NCT07052032 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis
NCT00213538 ·Status: COMPLETED
-
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD
NCT05936970 ·Status: RECRUITING
-
Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
NCT00116727 ·Status: COMPLETED
-
Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients
NCT00001679 ·Status: COMPLETED
-
Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice
NCT01692899 ·Status: COMPLETED
-
Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs
NCT03496831 ·Status: COMPLETED
-
Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
NCT00321217 ·Status: UNKNOWN
-
Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset
NCT00512239 ·Status: RECRUITING